the central bank in the currency- Top snippets

National Development and Reform Commission: Constantly improve investment policy tools and focus on expanding effective investment. It will close in 2024. How to further release the engine of domestic demand in 2025? Chengfeng Zhao, deputy director of the Investment Department of the National Development and Reform Commission, said that the National Development and Reform Commission will pay equal attention to quality and efficiency, constantly improve investment policy tools, focus on expanding effective investment, give full play to the key role of investment, and promote economic growth and structural optimization.Many European countries suspended the processing of asylum applications from Syrian citizens. On December 9, local time, due to the situation in Syria, Sweden, Austria and the Czech Republic announced that they would suspend the processing of asylum applications from Syrian citizens. Previously, several European countries, including the Netherlands, Germany, Denmark, Belgium, Croatia and Italy, have suspended accepting asylum applications from Syrian citizens.The national medical insurance drug list was adjusted to promote the upgrading of the pharmaceutical industry. The National Medical Insurance Bureau recently held the 2024 medical insurance drug list adjustment and interpretation activity. Huang Xinyu, director of the Medical Service Management Department of the National Medical Insurance Bureau, said that the National Medical Insurance Bureau selected drugs with great clinical value and high degree of innovation by adjusting the drug list, calculating and negotiating, and gave them reasonable prices, which helped to better lead the innovation and development of the pharmaceutical industry. In recent years, the medical insurance fund has invested hundreds of billions to support the innovative development of the pharmaceutical industry with real money. (CSI)

Google: We are cooperating with Intersect Power and TPG Rise to develop industrial parks with gigawatt data center capacity and new clean energy power plants.On December 9, the top 20 US stock turnover: Apple hit a record high, with a market value exceeding 3.7 trillion US dollars. On Monday, Apple, the fifth US stock turnover, closed up 1.61%, and its share price reached a record high, with a turnover of 10.425 billion US dollars and a market value of about 3.73 trillion US dollars. It is reported that by 2025, a quarter of Apple's iPhone will be produced outside China, and India will become the most likely production base. As a fast-growing market, India has hundreds of millions of potential customers, and Samsung and China brands have launched fierce competition here. According to market research firm IDC, the average price of smartphones in India has risen from $192 in the third quarter of 2020 to $293 in the same period of 2024. Apple's market share increased by nearly 60% from the third quarter of 2023 to 2024, which was partly due to its launch of the old iPhone which was more close to the people. (Global Market Broadcast)Hungarian Prime Minister Orban met with President-elect Trump and his DOGE Minister-designate Musk at his Haihu Manor.

The China ETF rose more than 24% when the three indexes of US stocks collectively closed down three times, while the three indexes of US stocks collectively closed down, with the Dow down 0.54%, the Nasdaq down 0.62% and the S&P 500 down 0.61%. The Political Bureau of the Central Committee set the tone for economic work in 2025, releasing multiple positive signals. China ETF rose by more than 24% and Nasdaq China Jinlong Index rose by more than 8% when China Stock Exchange went on a collective carnival. The sudden change in the political situation in Syria pushed precious metals, and gold and silver mining stocks rose across the board. Cordelian Mining rose by more than 7% and Pan American Silver rose by more than 5%.The annual demand peak season is coming, and the price of pigs is going down actively. By the end of the year, the two festivals are approaching, and the pig breeding industry is gradually entering the annual demand peak season. Recently, the production and sales data of November disclosed by listed aquaculture companies showed that the market price of live pigs in that month was down from the previous month. Zou Yingji, an analyst at Zhuo Chuang Information, believes that the overall price of live pigs in November showed a trend of first falling and then rising. In the first half of November, the mentality of some operators was relaxed, and the pig sources for secondary fattening in the early stage were released one after another, and the supply of pig sources in the market increased obviously. However, because the temperature did not drop significantly, the downstream receiving efforts were limited, and the terminal delivery speed was slow, and the market was in an oversupply situation, which led to the downward trend of pig prices in the first half of November. In the late stage, the temperature in some areas gradually decreased, and some southern markets started the curing action one after another, and the demand side improved slightly, which supported the price of live pigs to stop falling and rebound. However, because the cured meat is only opened sporadically, the increase of demand side is limited, and there is not much room for the rebound of pig prices. After entering December, the increase in domestic pig prices failed to continue. Zou Yingji believes that at present, in order to ensure the smooth completion of the annual slaughter plan, the enthusiasm for slaughtering pigs is high, and farmers also have large-weight pigs to be slaughtered or released in the pickling season. The supply of pigs may still be abundant in December.The national medical insurance drug list was adjusted to promote the upgrading of the pharmaceutical industry. The National Medical Insurance Bureau recently held the 2024 medical insurance drug list adjustment and interpretation activity. Huang Xinyu, director of the Medical Service Management Department of the National Medical Insurance Bureau, said that the National Medical Insurance Bureau selected drugs with great clinical value and high degree of innovation by adjusting the drug list, calculating and negotiating, and gave them reasonable prices, which helped to better lead the innovation and development of the pharmaceutical industry. In recent years, the medical insurance fund has invested hundreds of billions to support the innovative development of the pharmaceutical industry with real money. (CSI)